Brief: AcelRx Pharmaceuticals Received Nasdaq Notice Of Non-Compliance With Market Value Of Listed Securities Requirement

Talphera

09/05/2022 22:49

May 9 (Reuters) - AcelRx Pharmaceuticals Inc  ACRX.O :
    * ACELRX PHARMACEUTICALS -  ON MAY 6, RECEIVED NOTICE FROM
NASDAQ
THAT CO IS NOT IN COMPLIANCE WITH MARKET VALUE OF LISTED
SECURITIES REQUIREMENT
    * ACELRX PHARMACEUTICALS INC - INTENDS TO MONITOR MARKET
VALUE OF
ITS COMMON STOCK AND WILL EVALUATE AVAILABLE OPTIONS TO REGAIN
COMPLIANCE WITH NASDAQ
    * ACELRX PHARMACEUTICALS INC - NOTICE DOES NOT IMPACT
LISTING OF
COMPANY'S COMMON STOCK ON NASDAQ GLOBAL MARKET AT THIS TIME

Source text for Eikon: [https://bit.ly/3M3r39m]
Further company coverage:  ACRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))